Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | April 05, 2022

ITC Monthly Wrap-Up: March 2022

Blog | April 04, 2022

European Patent Office Updates Procedure for Issuing Grant Certificates

Blog | April 04, 2022

Texas Patent Litigation Monthly Wrap-Up: March 2022

Blog | March 08, 2022

The Basics of TTAB Cancellations

Blog | February 25, 2022

European Patent Office to Increase Fees on April 1, 2022

Blog | February 09, 2022

ITC Monthly Wrap-Up: January 2022

Blog | February 02, 2022

Texas Patent Litigation Monthly Wrap-Up: January 2022

Blog | January 21, 2022

ITC Monthly Wrap-Up: December 2021

Blog | January 20, 2022

Legal Alert: Unified Patent Court and Unitary Patent Moving Ahead in Europe

Blog | January 19, 2022

REGENXBIO v. SAREPTA: Make Sure You're Safely Within the Safe Harbor Before Using a "Research Tool"

Blog | January 15, 2022

Texas Patent Litigation Monthly Wrap-Up: December 2021

Blog | January 11, 2022

Biosimilars 2021 Year in Review